Pomanda estimates the enterprise value of E & O LABORATORIES LIMITED at £14.7m based on a Turnover of £13.8m and 1.06x industry multiple (adjusted for size and gross margin).
e & o laboratories limitedEstimated Valuation
£13.9m
Pomanda estimates the enterprise value of E & O LABORATORIES LIMITED at £13.9m based on an EBITDA of £2.1m and a 6.59x industry multiple (adjusted for size and gross margin).
e & o laboratories limitedEstimated Valuation
£37.8m
Pomanda estimates the enterprise value of E & O LABORATORIES LIMITED at £37.8m based on Net Assets of £18.7m and 2.02x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
E & O Laboratories LimitedOverview
E & O Laboratories Limited is a live company located in stirlingshire, FK4 2HH with a Companies House number of SC125360. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in May 1990, it's largest shareholder is
e & o laboratories employee ownership trustee ltd
with a 62.5% stake. E & O Laboratories Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£13.8m with
declining
growth in recent years.
Pomanda's financial health check has awarded E & O Laboratories Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
6 Strong
4 Regular
2 Weak
Size
annual sales of £13.8m, make it in line with the average company (£13.8m)
£13.8m - E & O Laboratories Limited
£13.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -35%, show it is growing at a slower rate (9.1%)
-35% - E & O Laboratories Limited
9.1% - Industry AVG
Production
with a gross margin of 48.1%, this company has a lower cost of product (30.3%)
48.1% - E & O Laboratories Limited
30.3% - Industry AVG
Profitability
an operating margin of 9.3% make it more profitable than the average company (6.4%)
9.3% - E & O Laboratories Limited
6.4% - Industry AVG
Employees
with 121 employees, this is above the industry average (70)
121 - E & O Laboratories Limited
70 - Industry AVG
Pay Structure
on an average salary of £32.7k, the company has a lower pay structure (£42.4k)
£32.7k - E & O Laboratories Limited
£42.4k - Industry AVG
Efficiency
resulting in sales per employee of £114.2k, this is less efficient (£177.9k)
£114.2k - E & O Laboratories Limited
£177.9k - Industry AVG
Debtor Days
it gets paid by customers after 49 days, this is near the average (52 days)
49 days - E & O Laboratories Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 38 days, this is close to average (40 days)
38 days - E & O Laboratories Limited
40 days - Industry AVG
Stock Days
it holds stock equivalent to 72 days, this is in line with average (65 days)
72 days - E & O Laboratories Limited
65 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 129 weeks, this is more cash available to meet short term requirements (13 weeks)
129 weeks - E & O Laboratories Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 14.8%, this is a lower level of debt than the average (47.4%)
14.8% - E & O Laboratories Limited
47.4% - Industry AVG
E & O LABORATORIES LIMITED financials
EXPORT
E & O Laboratories Limited's latest turnover from May 2024 is £13.8 million and the company has net assets of £18.7 million. According to their latest financial statements, E & O Laboratories Limited has 121 employees and maintains cash reserves of £7.4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Turnover
13,818,095
16,664,734
31,708,523
49,280,573
11,156,879
6,085,425
7,374,064
6,758,046
6,964,843
5,069,372
5,077,175
3,855,674
4,130,138
3,878,277
4,576,224
Other Income Or Grants
Cost Of Sales
7,171,510
7,928,134
10,603,260
11,143,165
7,856,631
4,231,209
5,118,538
4,548,743
4,693,120
3,463,688
3,440,768
2,620,767
2,791,785
2,625,271
3,061,062
Gross Profit
6,646,585
8,736,600
21,105,263
38,137,408
3,300,248
1,854,216
2,255,525
2,209,303
2,271,723
1,605,685
1,636,408
1,234,907
1,338,353
1,253,006
1,515,163
Admin Expenses
5,359,735
5,837,230
4,678,262
3,886,850
754,789
1,293,848
2,090,738
2,208,387
1,924,443
918,451
1,269,385
945,675
1,171,966
972,300
163,984
Operating Profit
1,286,850
2,899,370
16,427,001
34,250,558
2,545,459
560,368
164,787
916
347,280
687,234
367,023
289,232
166,387
280,706
1,351,179
Interest Payable
11,129
Interest Receivable
1,017,942
345,995
14,568
507
1,994
8,044
2,912
1,912
6,199
5,070
2,576
1,995
2,175
1,831
806
Pre-Tax Profit
2,304,792
3,245,365
16,442,985
34,250,466
2,547,453
568,412
167,699
2,828
353,479
692,304
369,599
291,227
168,562
282,536
1,351,985
Tax
-621,704
-434,459
-3,069,543
-6,693,891
-484,016
-107,998
-31,863
-537
-70,696
-138,461
-77,616
-66,982
-40,455
-73,459
-378,556
Profit After Tax
1,683,088
2,810,906
13,373,442
27,556,575
2,063,437
460,414
135,836
2,291
282,783
553,843
291,983
224,245
128,107
209,077
973,429
Dividends Paid
Retained Profit
1,683,088
2,810,906
13,373,442
27,556,575
2,063,437
460,414
135,836
2,291
282,783
553,843
291,983
224,245
128,107
209,077
973,429
Employee Costs
3,955,742
4,062,856
3,649,801
3,668,924
3,891,735
1,485,572
1,875,013
1,699,052
1,698,354
1,142,251
1,167,481
935,718
1,007,324
948,178
1,151,902
Number Of Employees
121
130
142
154
106
41
53
50
51
35
37
30
32
31
39
EBITDA*
2,105,253
3,831,120
17,265,733
34,995,332
3,032,338
941,571
534,380
385,562
643,478
865,631
539,752
442,399
323,596
445,268
1,501,167
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Tangible Assets
7,804,070
9,345,307
6,258,968
6,076,529
4,663,096
4,627,075
4,939,676
4,720,338
2,304,727
1,314,390
1,292,229
1,282,596
543,121
611,432
554,353
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
7,804,070
9,345,307
6,258,968
6,076,529
4,663,096
4,627,075
4,939,676
4,720,338
2,304,727
1,314,390
1,292,229
1,282,596
543,121
611,432
554,353
Stock & work in progress
1,434,183
1,499,340
1,232,236
1,467,249
645,776
616,754
528,051
507,254
465,371
444,001
411,704
336,052
279,722
240,151
208,883
Trade Debtors
1,870,554
6,485,284
5,726,187
17,021,631
1,710,194
878,424
1,188,512
1,207,253
1,254,104
1,027,625
1,073,498
900,555
837,303
796,649
948,936
Group Debtors
Misc Debtors
209,095
1,023,448
657,938
109,725
Cash
7,352,867
34,549,425
41,188,754
24,427,843
2,622,895
1,365,854
779,209
385,625
1,143,941
1,335,505
692,506
337,906
460,121
409,854
322,487
misc current assets
3,324,208
510,272
308,821
303,514
total current assets
14,190,907
43,557,497
48,805,115
43,026,448
4,978,865
2,861,032
2,495,772
2,100,132
2,863,416
2,807,131
2,177,708
1,574,513
2,087,418
1,755,475
1,783,820
total assets
21,994,977
52,902,804
55,064,083
49,102,977
9,641,961
7,488,107
7,435,448
6,820,470
5,168,143
4,121,521
3,469,937
2,857,109
2,630,539
2,366,907
2,338,173
Bank overdraft
Bank loan
Trade Creditors
751,410
2,037,506
686,903
1,383,831
2,108,683
1,811,893
2,126,575
1,796,737
1,666,594
994,495
990,154
530,282
908,765
857,691
981,445
Group/Directors Accounts
1,330,023
226,329
other short term finances
hp & lease commitments
other current liabilities
872,676
705,356
6,637,285
13,203,625
total current liabilities
2,954,109
2,969,191
7,324,188
14,587,456
2,108,683
1,811,893
2,126,575
1,796,737
1,666,594
994,495
990,154
530,282
908,765
857,691
981,445
loans
hp & lease commitments
Accruals and Deferred Income
475,956
117,086
80,769
other liabilities
1,011,930
1,195,661
2,089,747
2,332,437
2,404,744
2,248,943
678,109
697,836
619,294
770,166
378,269
317,344
375,049
provisions
302,912
390,289
471,503
436,840
101,535
108,032
158,973
47,506
32,648
20,803
31,892
8,366
7,250
total long term liabilities
302,912
866,245
1,483,433
1,632,501
2,206,833
2,413,206
2,506,279
2,356,975
837,082
745,342
651,942
790,969
410,161
325,710
382,299
total liabilities
3,257,021
3,835,436
8,807,621
16,219,957
4,315,516
4,225,099
4,632,854
4,153,712
2,503,676
1,739,837
1,642,096
1,321,251
1,318,926
1,183,401
1,363,744
net assets
18,737,956
49,067,368
46,256,462
32,883,020
5,326,445
3,263,008
2,802,594
2,666,758
2,664,467
2,381,684
1,827,841
1,535,858
1,311,613
1,183,506
974,429
total shareholders funds
18,737,956
49,067,368
46,256,462
32,883,020
5,326,445
3,263,008
2,802,594
2,666,758
2,664,467
2,381,684
1,827,841
1,535,858
1,311,613
1,183,506
974,429
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Operating Activities
Operating Profit
1,286,850
2,899,370
16,427,001
34,250,558
2,545,459
560,368
164,787
916
347,280
687,234
367,023
289,232
166,387
280,706
1,351,179
Depreciation
818,403
931,750
838,732
744,774
486,879
381,203
369,593
384,646
296,198
178,397
172,729
153,167
157,209
164,562
149,988
Amortisation
Tax
-621,704
-434,459
-3,069,543
-6,693,891
-484,016
-107,998
-31,863
-537
-70,696
-138,461
-77,616
-66,982
-40,455
-73,459
-378,556
Stock
-65,157
267,104
-235,013
821,473
29,022
88,703
20,797
41,883
21,370
32,297
75,652
56,330
39,571
31,268
208,883
Debtors
-5,429,083
1,124,607
-10,747,231
15,421,162
831,770
-310,088
-18,741
-46,851
226,479
-45,873
172,943
63,252
40,654
-152,287
948,936
Creditors
-1,286,096
1,350,603
-696,928
-724,852
296,790
-314,682
329,838
130,143
672,099
4,341
459,872
-378,483
51,074
-123,754
981,445
Accruals and Deferred Income
-308,636
-5,455,973
-6,566,340
13,086,539
36,317
80,769
Deferred Taxes & Provisions
-87,377
-81,214
34,663
436,840
-101,535
-6,497
-50,941
111,467
14,858
11,845
-11,089
23,526
1,116
7,250
Cash flow from operations
5,295,680
-2,181,634
17,949,829
24,857,333
2,020,637
719,510
823,802
469,195
1,108,499
759,945
685,258
-133,737
277,516
370,190
953,487
Investing Activities
capital expenditure
-522,900
-68,602
-588,931
-2,800,257
-1,286,535
-200,558
-182,362
-892,642
-88,898
-221,641
-704,341
Change in Investments
cash flow from investments
-522,900
-68,602
-588,931
-2,800,257
-1,286,535
-200,558
-182,362
-892,642
-88,898
-221,641
-704,341
Financing Activities
Bank loans
Group/Directors Accounts
1,103,694
226,329
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
-1,011,930
-183,731
-894,086
-242,690
-72,307
155,801
1,570,834
-19,727
78,542
-150,872
391,897
60,925
-57,705
375,049
share issue
-32,012,500
1,000
interest
1,017,942
345,995
14,568
-10,622
1,994
8,044
2,912
1,912
6,199
5,070
2,576
1,995
2,175
1,831
806
cash flow from financing
-29,890,864
-439,606
-169,163
-904,708
-240,696
-64,263
158,713
1,572,746
-13,528
83,612
-148,296
393,892
63,100
-55,874
376,855
cash and cash equivalents
cash
-27,196,558
-6,639,329
16,760,911
21,804,948
1,257,041
586,645
393,584
-758,316
-191,564
642,999
354,600
-122,215
50,267
87,367
322,487
overdraft
change in cash
-27,196,558
-6,639,329
16,760,911
21,804,948
1,257,041
586,645
393,584
-758,316
-191,564
642,999
354,600
-122,215
50,267
87,367
322,487
e & o laboratories limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for e & o laboratories limited. Get real-time insights into e & o laboratories limited's credit score, group structure and payment trends.
Perform a competitor analysis for e & o laboratories limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in FK4 area or any other competitors across 12 key performance metrics.
e & o laboratories limited Ownership
E & O LABORATORIES LIMITED group structure
E & O Laboratories Limited has no subsidiary companies.
Ultimate parent company
E & O LABORATORIES LIMITED
SC125360
E & O LABORATORIES LIMITED Shareholders
The largest shareholders in E & O Laboratories Limited include E & O Laboratories Employee Ownership Trustee Ltd and Virginia Lucey.
e & o laboratories employee ownership trustee ltd
62.5%
virginia lucey
37.5%
e & o laboratories limited directors
E & O Laboratories Limited currently has 3 directors.
The longest serving directors include
Ms Virginia Lucey (May 1990) and
Mrs Judith Dawkins (Mar 1999).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to e & o laboratories limited. Currently there are 1 open charges and 2 have been satisfied in the past.
e & o laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for E & O LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
e & o laboratories limitedCompanies House Filings - See Documents
